Management of alcohol misuse in patients with liver diseases

被引:14
作者
Peng, Jennifer L. [1 ]
Patel, Milan Prakash [1 ]
McGee, Breann [1 ]
Liang, Tiebing [1 ]
Chandler, Kristina [1 ]
Tayarachakul, Sucharat [1 ,2 ]
O'Connor, Sean [3 ,4 ]
Liangpunsakul, Suthat [1 ,4 ,5 ]
机构
[1] Indiana Univ, Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA
[2] Oklahoma Area Tribal Epidemiol Ctr, Southern Plains Tribal Hlth Board, Oklahoma City, OK USA
[3] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA
[5] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
关键词
Alcohol Drinking; Liver Diseases; Disease Management; IDENTIFICATION TEST AUDIT; C VIRUS-INFECTION; CARBOHYDRATE-DEFICIENT TRANSFERRIN; USE DISORDERS; LIPID-METABOLISM; BINGE DRINKING; UNITED-STATES; HEPATITIS-B; FATTY LIVER; ETHANOL;
D O I
10.1136/jim-2016-000254
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Excessive alcohol use not only causes alcoholic liver disease (ALD) but also increases the risk of liver-related mortality in patients who already have other chronic liver diseases. Screening for alcohol misuse or alcohol use disorder (AUD) among patients with underlying liver disease is essential. This clinical review covers what is known about ALD, the impact of alcohol in patients with underlying liver diseases, current management of alcohol misuse and AUD, and the management of alcohol misuse and AUD specifically in patients with liver diseases. Several treatment options for alcohol misuse and AUD exist such as psychosocial intervention and behavioral and pharmacological therapies. The strategies used in the treatment of alcohol misuse and AUD are still applicable in those who consume alcohol and have underlying liver disease. However, certain medications still need to be carefully used due to potentially worsening already compromised liver function. Screening of ongoing alcohol use in subjects with liver disease is important, and prompt intervention is needed to prevent the associated morbidity and mortality from the detrimental effects of continued alcohol use on underlying liver disease. Considering alcoholism is a complex disease, probably a multidisciplinary approach combining psychotherapy and comprehensive medical care will be the most effective. Future research could focus on identifying additional treatment options for addressing the psychotherapy component since the self-determination and will to quit drinking alcohol can play such a crucial role in promoting abstinence.
引用
收藏
页码:673 / 680
页数:8
相关论文
共 70 条
[1]   The Alcohol Use Disorders Identification Test (AUDIT) and its derivatives in screening for heavy drinking among the elderly [J].
Aalto, Mauri ;
Alho, Hannu ;
Halme, Jukka T. ;
Seppa, Kaija .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (09) :881-885
[2]   Baclofen: a new drug for the treatment of alcohol dependence [J].
Addolorato, G. ;
Leggio, L. ;
Agabio, R. ;
Colombo, G. ;
Gasbarrini, G. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) :1003-1008
[3]   Baclofen in the treatment of alcohol withdrawal syndrome: A comparative study vs diazepam [J].
Addolorato, G ;
Leggio, L ;
Abenavoli, L ;
Agabio, R ;
Caputo, F ;
Capristo, E ;
Colombo, G ;
Gessa, GL ;
Gasbarrini, G .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (03) :276.e13-276.e18
[4]   Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study [J].
Addolorato, Giovanni ;
Leggio, Lorenzo ;
Ferrulli, Anna ;
Cardone, Silvia ;
Vonghia, Luisa ;
Mirijello, Antonio ;
Abenavoli, Ludovico ;
D'Angelo, Cristina ;
Caputo, Fabio ;
Zambon, Antonella ;
Haber, Paul S. ;
Gasbarrini, Giovanni .
LANCET, 2007, 370 (9603) :1915-1922
[5]   Management of Alcohol Abuse [J].
Albanese, Anthony P. .
CLINICS IN LIVER DISEASE, 2012, 16 (04) :737-+
[6]  
[Anonymous], ALC AL BRIEF INT ALC
[7]  
[Anonymous], NAT I HLTH NAT I ALC
[8]   Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial [J].
Anton, RF ;
O'Malley, SS ;
Ciraulo, DA ;
Cisler, RA ;
Couper, D ;
Donovan, DM ;
Gastfriend, DR ;
Hosking, JD ;
Johnson, BA ;
LoCastro, JS ;
Longabaugh, R ;
Mason, BJ ;
Mattson, ME ;
Miller, WR ;
Pettinati, HM ;
Randall, CL ;
Swift, R ;
Weiss, RD ;
Williams, LD ;
Zweben, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (17) :2003-2017
[9]   Prevalence of and risk factors for hepatic steatosis in northern Italy [J].
Bellentani, S ;
Saccoccio, G ;
Masutti, F ;
Crocè, LS ;
Brandi, G ;
Sasso, F ;
Cristanini, G ;
Tiribelli, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117
[10]   COMPARISON OF CAGE QUESTIONNAIRE AND COMPUTER-ASSISTED LABORATORY PROFILES IN SCREENING FOR COVERT ALCOHOLISM [J].
BERESFORD, TP ;
BLOW, FC ;
HILL, E ;
SINGER, K ;
LUCEY, MR .
LANCET, 1990, 336 (8713) :482-485